To investigate the value of effluent lipopolysaccharide (LPS) for early detection of gram-negative peritonitis (GNP) in peritoneal dialysis (PD) patients.
Methods:
PD-related peritonitis episodes occurring between January 2016 and December 2018 were included in the study. Effluent LPS and the other infectious parameters were measured at peritonitis presentation, and peritonitis was categorized as GNP, non-GNP, and culture-negative peritonitis. Receiver operating characteristic (ROC) analysis was employed to evaluate the efficacy of effluent LPS to distinguish GNP.
Results:
A total of 161 peritonitis episodes were analyzed, including 49 GNP episodes and 82 non-GNP episodes. In contrast with non-GNP, GNP presented with higher effluent leukocyte count (3236 (1497–6144) vs. 1904 (679–4071) cell mm−3, p = 0.008), increased effluent LPS (1.552 (0.502–2.500) vs. 0.016 (0.010–0.030) EU mL−1, p < 0.001), lower blood leukocyte count (9.95 ± 3.18 vs. 11.56 ± 4.37 × 109 L−1, p = 0.017), greater neutrophil predominance (87.1 ± 4.6% vs. 83.4 ± 7.7%, p = 0.001), and greater “procalcitonin” (PCT, 4.90 (2.20–12.60) vs. 1.00 (0.51–4.07) µg L−1, p < 0.001). It took 5.2 ± 3.1 h to report the results of effluent LPS. Effluent LPS cutoff value of >0.035 EU mL−1 showed an area under the ROC curve of 0.972 (95% CI 0.951–0.994, p < 0.001) in differentiating GNP from non-GNP with a sensitivity of 100% and a specificity of 80.5%, and its joint utilization with PCT further increased the specificity (91.4%) to discriminate GNP.
Conclusions:
PD effluent LPS could be an applicable early marker of gram-negative organism-related peritonitis in PD patients.
ChoYJohnsonDW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis2014; 64(2): 278–289.
2.
SutcliffeIC. A phylum level perspective on bacterial cell envelope architecture. Trends Microbiol2010; 18(10): 464–470.
3.
ButtenschoenKRadermacherPBrachtH. Endotoxin elimination in sepsis: physiology and therapeutic application. Langenbecks Arch Surg2010; 395: 597–605.
4.
TanYKaganJC. A cross-disciplinary perspective on the innate immune responses to bacterial lipopolysaccharide. Mol Cell2014; 54: 212–223.
5.
DasAPKumarPSSwainS. Recent advances in biosensor based endotoxin detection. Biosens Bioelectron2014; 51: 62–75.
6.
NachumR. Usefulness of LAL assay for rapid detection of gram-negative bacteriuria. Prog Clin Biol Res1987; 231: 431–442.
7.
HobanDJWitwickiEHammondGW. Bacterial antigen detection in cerebrospinal fluid of patients with meningitis. Diagn Microbiol Infect Dis1985; 3: 373–379.
8.
MazorMWiznitzerAChaimW, et al.Limulus amebocyte lysate assay for diagnosing intraamniotic infection [in Hebrew]. Harefuah1992; 123: 439–443, 508.
9.
OsnesTKierulfPSkarV, et al.Quantification of lipopolysaccharides in human bile with or without gram-negative bacteria. Scand J Gastroenterol1992; 27: 453–458.
10.
ClaymanMDRaymondAColenD, et al.The Limulus amebocyte lysate assay. A rapid and sensitive method for diagnosing early gram-negative peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Arch Intern Med1987; 147: 337–440.
11.
PeerGSerbanIBlumM, et al.Early diagnosis of gram-negative peritonitis in continuous ambulatory peritoneal dialysis patients with the Lymulus amebocyte lysate assay. Am J Nephrol1992; 12: 19–21.
12.
MuhammedKOOzenerQAkogluE. Diagnostic value of effluent endotoxin level in gram-negative peritonitis in CAPD patients. Perit Dial Int2001; 21: 154–157.
13.
BowmanRAMedleyASKarthigasuKT. Limulus amoebocyte lysate assay in the diagnosis of peritonitis in patients receiving continuous ambulatory peritoneal dialysis. J Clin Pathol1992; 45: 72–74.
14.
HausmannMJYulzariRLewisE, et al.Gel clot LAL assay in the initial management of peritoneal dialysis patients with peritonitis: a retrospective study. Nephrol Dial Transplant2000; 15: 680–683.
15.
SzetoCCLaiKBChowKM, et al.Dialysate bacterial endotoxin as a prognostic indicator of peritoneal dialysis related peritonitis. Nephrology (Carlton)2016; 21: 1069–1072.
16.
LiPKSzetoCCPirainoB, et al.ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int2016; 36: 481–508.
17.
PengYYeHYiC, et al.Changes in outcomes over time among incident peritoneal dialysis patients in Southern China. Perit Dial Int2019; 39: 382–389.
18.
Nadeau-FredetteACJohnsonDWHawleyCM, et al.Center-specific factors associated with peritonitis risk-a multi-center registry analysis. Perit Dial Int2016; 36: 509–518.
19.
OngLMCh’ngCCWeeHC, et al.Risk of peritoneal dialysis-related peritonitis in a multi-racial Asian population. Perit Dial Int2017; 37: 35–43.
20.
ZähringerULindnerBRietschelET. Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides. Adv Carbohydr Chem Biochem1994; 50: 211–276.
21.
Laude-SharpMHaeffner-CavaillonNCaroffM, et al.Dissociation between the interleukin 1-inducing capacity and Limulus reactivity of lipopolysaccharides from gram-negative bacteria. Cytokine1990; 2: 253–258.
22.
SteeghsLden HartogRden BoerA, et al.Meningitis bacterium is viable without endotoxin. Nature1998; 392: 449–450.
23.
PengDHongWChoudhuryBP, et al.Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate. Infect Immun2005; 73: 7569–7577.
24.
MoffattJHHarperMHarrisonP, et al.Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother2010; 54: 4971–4977.
25.
HaakeDAZückertWR. The leptospiral outer membrane. Curr Top Microbiol Immunol2015; 387: 187–221.
26.
MoritaTNakamuraTMiyataT, et al.Biochemical characterisation of Limulus clotting factors and inhibitors which interact with bacterial endotoxin. Prog Clin Biol Res1985; 189: 53–66.
27.
ElinRJWolffSM. Nonspecificity of the Limulus amoebocyte lysate test: positive reactions with polynucleotides and proteins. J Infect Dis1973; 128: 349–352.
28.
BrynKSolbergOAndersenBM. Endotoxin liberation studied by biological and chemical methods. Chemical characterization of six meningococcal lipopolysaccharides. APMIS1989; 97: 429–435.
29.
Mattsby-BaltzerILindgrenKLindholmB, et al.Endotoxin shedding by enterobacteria: free and cell-bound endotoxin differ in Limulus activity. Infect Immun1991; 59: 689–695.
30.
WildfeuerAHeymerBSchleiferKH, et al.Investigations on the specificity of the Limulus test for the detection of endotoxin. Appl Microbiol1974; 28: 867–891.
MoritaTTanakaSNakamuraT, et al.A new (1-3) β-D-glucan mediated coagulation pathway found in Limulus amoebocytes. FEBS Letters1981; 129: 318–321.
33.
KimSHJeongHSKimYH, et al.Evaluation of DNA extraction methods and their clinical application for direct detection of causative bacteria in continuous ambulatory peritoneal dialysis culture fluids from patients with peritonitis by using broad-range PCR. Ann Lab Med2012; 32: 119–125.
34.
ChangYTWangHCWangMC, et al.Rapid identification of bacteria and Candida pathogens in peritoneal dialysis effluent from patients with peritoneal dialysis-related peritonitis by use of multilocus PCR coupled with electrospray ionization mass spectrometry. J Clin Microbiol2014; 52: 1217–1219.
35.
LamJYWuAKLeungWS, et al.Gordonia species as emerging causes of continuous-ambulatory-peritoneal-dialysis-related peritonitis identified by 16 S rRNA and secA1 gene sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF/MS). J Clin Microbiol2015; 53: 671–676.
36.
BatesDWParsonnetJKetchumPA, et al.Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group. Clin Infect Dis1998; 27: 582–591.
37.
VenetCZeniFViallonA, et al.Endotoxaemia in patients with severe sepsis or septic shock. Intensive Care Med2000; 26: 538–544.
38.
MartinoFScalzottoEGiavarinaD, et al.The role of NGAL in peritoneal dialysis effluent in early diagnosis of peritonitis: case-control study in peritoneal dialysis patients. Perit Dial Int2015; 35: 559–565.
39.
GuzGColakBHizelK, et al.Procalcitonin and conventional markers of inflammation in peritoneal dialysis patients and peritonitis. Perit Dial Int2006; 26: 240–248.
40.
LamMFLeungJCLamCW, et al.Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis. Perit Dial Int2008; 28: 377–384.
